These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 5998248)
41. The inhibition of chymotrypsin A4 and B with chloromethyl ketone reagents. Stevenson KJ; Smillie LB Can J Biochem; 1968 Nov; 46(11):1357-70. PubMed ID: 5687069 [No Abstract] [Full Text] [Related]
42. Concerning a reported change in rate-determining step in chymotrypsin catalysis. Zeeberg B; Caswell M; Caplow M J Am Chem Soc; 1973 Apr; 95(8):2734-5. PubMed ID: 4694533 [No Abstract] [Full Text] [Related]
43. Protection of chymotrypsin from inactivation by a nitrogen mustard antitumor drug by prior acylation of the active center. Stephens LE; Brecher AS Proc Soc Exp Biol Med; 1971 Jul; 137(3):966-8. PubMed ID: 5560689 [No Abstract] [Full Text] [Related]
47. Inhibition of chymotrypsin by phenyl N-phenyl-phosphoramidochloridate. Parkin J; Tomkinson NP; Virden R Biochem Soc Trans; 1992 Aug; 20(3):283S. PubMed ID: 1426567 [No Abstract] [Full Text] [Related]
48. Active site-directed inhibition with substrates producing carbonium ions: chymotrypsin. White EH; Roswell DF; Politzer IR; Branchini BR Methods Enzymol; 1977; 46():216-20. PubMed ID: 909409 [No Abstract] [Full Text] [Related]
49. The effect of borate on the carbazole reaction. GREGORY JD Arch Biochem Biophys; 1960 Aug; 89():157-9. PubMed ID: 13851710 [No Abstract] [Full Text] [Related]
50. Sex ratio of offspring of men exposed to sodium borates. James WH Occup Environ Med; 1995 Apr; 52(4):284. PubMed ID: 7795746 [No Abstract] [Full Text] [Related]
51. [On the pharmacological properties of o-anisylboric acid]. CAUJOLLE F; GOUT R; GOUT-TARBOURIECH Y; LAVAUR P Bull Acad Natl Med; 1960 Jan 19-26; 144():67-71. PubMed ID: 13808519 [No Abstract] [Full Text] [Related]
52. [Phenylboric acid and its central analgesic activity]. CAUJOLLE F; GAYREL P; IZARD G Bull Acad Natl Med; 1956 Jan 10-17; 140(1-2):11-4. PubMed ID: 13316263 [No Abstract] [Full Text] [Related]
53. The effect of large intravenous doses of sodium borate on the human myocardium as reflected in the electrocardiogram. CONN HL; ANTAL BB; FARR LE Circulation; 1955 Dec; 12(6):1043-6. PubMed ID: 13270360 [No Abstract] [Full Text] [Related]
54. Interaction of leuco-carbinol of brilliant green with active center of -chymotrypsin. Zarfolomeev SD; Martinek K; Berezin IV Mol Biol; 1972; 6(1):118-22. PubMed ID: 5086735 [No Abstract] [Full Text] [Related]
55. Effect of ionic strength of the steady-state kinetics of -chymotrypsin-catalyzed reactions. Martinek K; Yatsimirskii AK; Berezin IV Mol Biol; 1971; 5(1):77-88. PubMed ID: 5154806 [No Abstract] [Full Text] [Related]
56. Inactivation of alpha-chymotrypsin by a bifunctional reagent, 2-bromomethyl-3, I-benzoxazin-4-one. Alazard R; Béchet JJ; Dupaix A; Yon J Biochim Biophys Acta; 1973 Jun; 309(2):379-96. PubMed ID: 4731968 [No Abstract] [Full Text] [Related]
57. [Inhibitory effect of borates on the 3 step hydrolysis reaction of non-specific substrates by alpa chymotrypsin]. Berezin IV; Kolomiĭtseva GIa; Levashov AV; Martinek K Dokl Akad Nauk SSSR; 1966 Dec; 171(5):1213-6. PubMed ID: 5998248 [No Abstract] [Full Text] [Related]
58. The inhibitory effect of nonspecific substrates on the hydrolysis of ethyl-N-acetyl-L-tyrosinate by -chymotrypsin. Belikov VM; Martinkova NS Mol Biol; 1971; 5(1):99-101. PubMed ID: 5154808 [No Abstract] [Full Text] [Related]